John Berdahl

John Berdahl is a prominent ophthalmologist with extensive experience in refractive, cataract, cornea, and glaucoma surgery. Currently, John serves as the Founder and Chair of Balance Ophthalmics and holds various co-founder and board member roles at several companies, including Interfeen, ExpertOpinion.MD, and Melt Pharmaceuticals. From 2009, John has practiced at Vance Thompson Vision and previously led Equinox Ophthalmic, Inc. as Founder and Chief Medical Officer, focusing on innovative glaucoma treatments. John's early career includes advanced surgical training as a Fellow in Cornea, Glaucoma, and Refractive Surgery at Minnesota Eye Consultants and residency at Duke University. Recognized for excellence, John received multiple awards, including the 2008 Ophthalmology Times Writers Award and the Resident of the Year Award at Duke. Educational achievements include a Doctor of Medicine degree from Mayo Clinic Alix School of Medicine and a Bachelor’s degree in Physics, Chemistry, and Biology from Augustana University.